Skip to main content
HCONRES 75 109th Congress House Foreign Trade and International Finance Access to health care Canada Commerce Consumer education Consumer protection Crime and Law Enforcement Crime prevention Deregulation Drug approvals Drug industry Drugs Economics and Public Finance Health Health care industry Health education Imports Pharmaceutical research Prescription pricing Price discrimination

Expressing the sense of the Congress that the illegal importation of prescription drugs severely undermines the regulatory protections afforded to United States consumers, and for other purposes.

Introduced: February 17, 2005 Introduced by: Meeks, Gregory W. Democratic · New York See on congress.gov
Sign in to write a letter Sign in to watch
This resolution expired with the 109th Congress
It was not agreed to before the 109th Congress (2005–2006) adjourned, so it is no longer active. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
Mar 14, 2005
Referred to the Subcommittee on Health.
Feb 28, 2005
Referred to the Subcommittee on Health.
Feb 17, 2005
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 17, 2005
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Expresses the sense of Congress regarding the illegal importation of prescription drugs.

Urges the President to take action to prevent the illegal importation of prescription drugs from Canada or any other foreign country, and the U.S. Trade Representative to act to correct the inequities and discrimination caused by Canada's Patented Medicine Pricing Review Board.

Urges the pharmaceutical industry and the health care community to: (1) begin a nationwide educational awareness program for U.S. consumers regarding the dangers of imported drugs; and (2) work to ensure that all citizens have access to prescription drugs with the same level of safety and efficacy guaranteed under the current system of regulation.

Declares that: (1) it is essential that U.S. patients have access to affordable prescription drugs; and (2) deregulating foreign prices would increase the flow of new drugs to U.S. consumers.

What's happening now March 14, 2005

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
Cite this page click to expand
APA
U.S. Congress. (2026). H. Con. Res. 75: Expressing the sense of the Congress that the illegal importation of prescription drugs severely undermines the regulatory protections afforded to United States consumers, and for other purposes.. 109th Congress. Open America. https://openamerica.io/bill/109-HCONRES-75/
MLA
"H. Con. Res. 75: Expressing the sense of the Congress that the illegal importation of prescription drugs severely undermines the regulatory protections afforded to United States consumers, and for other purposes.." 109th Congress, 2026, Open America, https://openamerica.io/bill/109-HCONRES-75/.
Bluebook (legal)
H. Con. Res. 75, 109th Cong. (2026), https://openamerica.io/bill/109-HCONRES-75/.
Markdown link
[H. Con. Res. 75: Expressing the sense of the Congress that the illegal importation of prescription drugs severely undermines the regulatory protections afforded to United States consumers, and for other purposes.](https://openamerica.io/bill/109-HCONRES-75/)
Report a problem